Questions raised by the benelux CML study group: Results from the randomized study with hydroxyurea alone versus hydroxyurea combined with low-dose interferon-alpha 2b for chronic myeloid leukemia - Response

JC Kluin-Nelemans*, A Delannoy, A Louwagie, Benelux CML Study Grp

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

4 Citations (Scopus)
Original languageEnglish
Pages (from-to)2986-2987
Number of pages2
JournalBlood
Volume92
Issue number8
Publication statusPublished - 15-Oct-1998
Externally publishedYes

Keywords

  • CHRONIC MYELOGENOUS LEUKEMIA
  • REQUIRING PROLONGED OBSERVATION
  • PATIENT
  • DESIGN

Cite this